FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Biocon LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532523 NSE Symbol: BIOCON P/E (TTM) :0
ISIN Demat:INE376G01013 Div & Yield %:0.5 EPS (TTM) :0.4
Book Value (RS) :90.3831418 Market Cap (Rs Cr.):35849.92 Face Value (RS) :5
    Change Company 
Particulars Quarter Ended
(Dec 2023)		 Quarter Ended
(Dec 2022)		 Quarter Ended
(% Var)
Sales 562.80 555.00 1.41
Other Income 48.50 59.90 -19.03
PBIDT 119.80 97.00 23.51
Interest 56.00 21.40 161.68
PBDT 63.80 75.60 -15.61
Depreciation 30.90 29.10 6.19
PBT 32.90 46.50 -29.25
Tax 12.30 11.30 8.85
Deferred Tax -3.40 0.00 0.00
PAT 24.00 35.20 -31.82

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)